InvestorsHub Logo

BJ_Cooper

03/13/20 6:42 PM

#5416 RE: Biotech Pharmer #5415

While I disagree with your political stance, I do agree that it will be great to see AVEO get a vaccine fast tracked and on the market. If this were to happen, AVEO could easily become a $20 or more stock.
As for the political stuff, it’s ok to disagree. We’re all on the same team here with AVEO. Thanks for the great info!

enthalpy

03/13/20 7:35 PM

#5417 RE: Biotech Pharmer #5415

you really think aveo really is working on a fast track coronavirus vaccine? or is it hearsay?

enthalpy

03/14/20 10:34 AM

#5424 RE: Biotech Pharmer #5415

wow. check this out. a real possibility of being modified to treat common influenza cold viruses.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692129/

enthalpy

03/14/20 11:48 PM

#5427 RE: Biotech Pharmer #5415

If they meet the mile stones they will get paid up to 391 million from the partner plus high single digit to low double digit royalties from kirin who wanted the non ocology rights. I bet that if they do gamble and get a fast track approval working with that Japanese company for a coronavirus flu treatment this stock will rock with a 400 million payment plus royalties. That would this to $50 imo. Good luck to all.

https://www.businesswire.com/news/home/20190801005415/en/Kyowa-Kirin-Buys-Tivozanib-Non-Oncology-Rights-AVEO